We are live on ! Find out more
NAUT icon

Nautilus Biotechnolgy
NAUT

81 hedge funds and large institutions have $235M invested in Nautilus Biotechnolgy in 2021 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 24 increasing their positions, 13 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

529% more call options, than puts

Call options by funds: $2.04M | Put options by funds: $324K

85% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 13

69% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 13

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

14.95% more ownership

Funds ownership: 33.02% → 47.97% (+15%)

13% more funds holding

Funds holding: 72 → 81 (+9)

4% less capital invested

Capital invested by funds: $245M → $235M (-$10.3M)

Holders
81
Holders Change
+9
Holders Change %
+12.5%
% of All Funds
1.25%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
22
Increased
24
Reduced
13
Closed
13
Calls
$2.04M
Puts
$324K
Net Calls
+$1.71M
Net Calls Change
+$1.02M

Top Buyers

Rank Fund Capital Flow
1
AI
ArchPoint Investors
Florida
+$7.76M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$3.74M
3
TM
Tikvah Management
North Carolina
+$2.8M
4
CGL
Clarius Group LLC
Washington
+$2.19M
5
PA
Perceptive Advisors
New York
+$1.07M

Top Sellers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
-$4.91M
2
BC
Boxer Capital
California
-$4.61M
3
APM
Avidity Partners Management
Texas
-$3.68M
4
SCM
Suvretta Capital Management
New York
-$1.93M
5
ABG
Ally Bridge Group
New York
-$1.47M
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
26
Clearline Capital
New York
$1.18M +$371K +69,395 +44%
HC
27
Hillman Company
Pennsylvania
$1.04M – – –
State Street
28
State Street
Massachusetts
$918K +$104K +19,500 +12%
Susquehanna International Group
29
Susquehanna International Group
Pennsylvania
$820K -$298K -55,593 -26%
CS
30
Candriam SCA
Luxembourg
$803K – – –
Northern Trust
31
Northern Trust
Illinois
$748K +$288K +53,763 +59%
PVI
32
Pura Vida Investments
New York
$745K -$24.1K -4,502 -3%
SCP
33
Sender Company & Partners
New York
$742K +$767K +143,335 New
Ensign Peak Advisors
34
Ensign Peak Advisors
Utah
$698K +$721K +134,695 New
SGM
35
Skye Global Management
Florida
$570K +$345K +64,500 +142%
Millennium Management
36
Millennium Management
New York
$464K -$1.06M -198,092 -69%
Simplex Trading
37
Simplex Trading
Illinois
$418K +$419K +78,291 +3,209%
CSS
38
Cubist Systematic Strategies
Connecticut
$362K -$24.3K -4,547 -6%
Goldman Sachs
39
Goldman Sachs
New York
$299K +$253K +47,253 +453%
LOAMU
40
Lombard Odier Asset Management (USA)
New York
$259K – – –
DY
41
Dowling & Yahnke
California
$235K +$243K +45,350 New
VCWA
42
Vanguard Capital Wealth Advisors
Colorado
$235K +$244K +45,500 New
Morgan Stanley
43
Morgan Stanley
New York
$221K +$62.5K +11,675 +38%
Marshall Wace
44
Marshall Wace
United Kingdom
$195K -$688K -128,613 -77%
S
45
SignatureFD
Georgia
$193K +$200K +37,313 New
PP
46
Paloma Partners
Connecticut
$188K +$77.6K +14,503 +67%
AC
47
Aristides Capital
Kentucky
$187K +$193K +36,100 New
LP
48
LMR Partners
United Kingdom
$141K +$146K +27,248 New
AGM
49
Alpine Global Management
New York
$137K – – –
VF
50
Virtu Financial
New York
$132K +$136K +25,495 New
1
2
3 4

NAUT Hedge Fund Activity: Q4 2021 in Review

81 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Nautilus Biotechnolgy (NAUT) for Q4 2021, worth a combined $235M — down 4.2% from $245M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new NAUT positions and 13 closed out — a net gain of 9 holders — while 24 added to existing stakes and 13 trimmed.

The largest buyer was ArchPoint Investors, opening a new position worth an estimated $7.76M. The largest seller was Federated Hermes, exiting entirely with an estimated $4.91M sold.

  • 81 institutional investors held Nautilus Biotechnolgy (NAUT) as of Q4 2021, up from 72 in Q3 2021.
  • Funds reported $235M of Nautilus Biotechnolgy stock for Q4 2021, down 4.2% quarter-over-quarter.
  • 22 funds opened new Nautilus Biotechnolgy positions in Q4 2021 and 13 closed out, a net change of +9 holders.
  • The largest Nautilus Biotechnolgy buyer in Q4 2021 was ArchPoint Investors, an estimated $7.76M added.
  • The largest Nautilus Biotechnolgy seller in Q4 2021 was Federated Hermes, an estimated $4.91M sold.

Based on aggregated 13F filings for Q4 2021.